The present disclosure relates to methods of treating viral hepatitis, compoundsuseful in the treatment of viral hepatitis, and pharmaceutical compositionscomprising such compounds. In one embodiment, pharmaceutical compositionscomprising nitazoxanide, tizoxanide, or derivatives and/or mixtures thereofare provided, as well as methods of treating hepatitis C using such compositions.